✦ LIBER ✦

Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion

✍ Scribed by Naoki Fujita; Ryosuke Sugimoto; Satoshi Motonishi; Naohisa Tomosugi; Hideaki Tanaka; Masaki Takeo; Motoh Iwasa; Yoshinao Kobayashi; Hisao Hayashi; Masahiko Kaito; Yoshiyuki Takei

Book ID: 116651634
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 195 KB
Volume: 49
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2008.05.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of sustained virological resp

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

✍ Foster, Graham R.; Fried, Michael W.; Hadziyannis, Stephanos J.; Messinger, Diet 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 392 KB

Sustained virological response to pegint

Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response

✍ M. TRAPERO-MARUGÁN; L. GARCÍA-BUEY; C. MUÑOZ; N. E. QUINTANA; J. A. MORENO-MONTE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Bone mineral density and bone turnover i

Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin

✍ Redondo-Cerezo, E.; Casado-Caballero, F.; Martin-Rodriguez, J. L.; Hernandez-Que 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 221 KB

995 A dynamic model to predict sustained

995 A dynamic model to predict sustained virological response to combination peginterferon alfa-2A (40KD) (PEGASYS(®)) and ribavirin (COPEGUS(®)) therapy in patients with chronic hepatitis C

✍ FERENCI, P; FRIED, M; CHANEAC, M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Pretreatment prediction of virological r

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns

✍ Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Yen Hsieh; Ming-Lung Yu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

We read with great interest the article published in a recent issue of HEPATOLOGY. 1 Shirakawa et al. enrolled 120 patients with chronic hepatitis C (CHC) infected with genotype 1 hepatitis C virus (HCV-1) and high baseline viral loads (HVL), defined by HCV RNA levels Ն 10 5 international units (IU)